BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Acorda Therapeutics Announces Data on AMPYRA(TM) (dalfampridine) Presented at American Academy of Neurology Meeting

  April 13, 2010

   · 

  1 min read
• Policy

  Alkermes Submits Supplemental New Drug Application for VIVITROL(R) for the Treatment of Opioid Dependence

  April 13, 2010

   · 

  1 min read
• BioMidwest

  BIOCIUS Life Sciences, Inc., Drs. LaMarr & Miller, to Speak at the Society for Biomolecular Sciences Conference

  April 13, 2010

   · 

  1 min read
• Drug Development

  EntreMed, Inc. Begins Phase 2 Study For ENMD-2076 In Patients With Platinum Resistant Ovarian Cancer

  April 13, 2010

   · 

  1 min read
• Pharm Country

  CAS Medical Systems, Inc. Announces Grant of Patent in Japan for FORE-SIGHT Technology

  April 13, 2010

   · 

  1 min read
• Business

  Vital Images, Inc. to Collaborate With Arkansas Children’s Hospital to Develop Vitrea(R) Pediatric Cardiac Application for Pediatric Imaging at Lower Radiation Exposure

  April 13, 2010

   · 

  1 min read
• Biotech Bay

  XOMA (US) LLC Issued Two New U.S. Patents for Methods of Treating Type 2 Diabetes and Inflammatory Diseases Using Interleukin-1 Beta Antibodies

  April 13, 2010

   · 

  1 min read
• Pharm Country

  Henry Schein, Inc. Chairman and CEO to Ring The NASDAQ Stock Market Opening Bell

  April 13, 2010

   · 

  1 min read
• BioCapital

  Cytomedix Inc. Announces Going Concern Qualification

  April 13, 2010

   · 

  1 min read
• Drug Development

  Intercept Pharmaceuticals Presents Positive Phase II Results from Study of INT-747 Therapy in Primary Biliary Cirrhosis at EASL Company Also Presents Data on Novel Dual FXR/TGR5 Agonist INT-767

  April 13, 2010

   · 

  4 min read